NCT00099281View on ClinicalTrials.gov

DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

June 30, 2006

Conditions
Breast CancerMetastases
Interventions
DRUG

YMB 1002

Trial Locations (1)

Unknown

PharmOlam, London

Sponsors

Lead Sponsor

YM BioSciences
All Listed Sponsors
lead

YM BioSciences

INDUSTRY

NCT00099281 - DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer | Biotech Hunter | Biotech Hunter